The proportion of women in the HPV test plus Pap smear group who were found to have grade 2 or 3 lesions or cancer was 51% greater than the proportion of control women who were found to have such ...
Nuvectis Pharma shares fell steeply after updated data from its early-stage study evaluating NXP800 to treat an aggressive type of ovarian cancer showed that a change in the dosing schedule only ...